
More

More
Technology Platforms
With structure-based antigen design as the foundational technology.
More


Pipeline
Comprehensive and deep efforts towards the development of human papillomavirus (HPV) vaccines and many other innovative vaccines
and many other innovative vaccines
and many other innovative vaccines
More
Newsroom
-
BHGB Receives DSMB’s Recommendation with Respect to the First Primary Endpoint Analysis in the Phase III Clinical Trial of its Nonavalent HPV Vaccine in Indonesia
2025-01-07
-
BHGB Announces Positive Data Readout from Interim Analysis of the Phase Ⅲ Trial of Trivalent HPV Vaccine
2024-08-13
-
BHGB Obtains Drug Manufacturing License
2024-08-05